MapLight Therapeutics, Inc.
MPLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $136 | $166 | $0 |
| Gross Profit | $0 | -$136 | -$166 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $27,094 | $26,711 | $19,620 | $20,713 |
| G&A Expenses | $4,404 | $0 | $0 | $2,064 |
| SG&A Expenses | $4,404 | $3,817 | $3,756 | $2,064 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $31,498 | $30,528 | $23,376 | $22,777 |
| Operating Income | -$31,498 | -$30,664 | -$23,542 | -$22,777 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2,080 | $818 | $1,203 | $1,548 |
| Pre-Tax Income | -$29,418 | -$29,846 | -$22,339 | -$21,229 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$29,418 | -$29,846 | -$22,339 | -$21,229 |
| % Margin | – | – | – | – |
| EPS | -0.71 | -0.72 | -0.54 | -0.51 |
| % Growth | 1.4% | -33.3% | -5.9% | – |
| EPS Diluted | -0.71 | -0.72 | -0.54 | -0.51 |
| Weighted Avg Shares Out | 41,429 | 41,429 | 41,429 | 41,429 |
| Weighted Avg Shares Out Dil | 41,429 | 41,429 | 41,429 | 41,429 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,549 | $688 | $811 | $899 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $136 | $136 | $166 | $194 |
| EBITDA | -$31,362 | -$29,710 | -$22,173 | -$22,583 |
| % Margin | – | – | – | – |